Literature DB >> 20739809

R778L, H1069Q, and I1102T mutation study in neurologic Wilson disease.

Jayantee Kalita1, Bindu I Somarajan, Usha K Misra, Balraj Mittal.   

Abstract

There is paucity of the studies on mutations in neurologic Wilson disease (WD) in India. We studied H1069Q, R778L, I1102T mutations in 26 patients with neurologic WD from 25 families in north India. The basis of diagnosis of neurologic WD was clinical, Kayser-Fleischer (KF) ring, and ceruloplasmin. Data collected included: family history, clinical characteristics, laboratory data, ultrasound findings, magnetic resonance imaging (MRI) findings, and severity of the disease. DNA was isolated from venous blood and subjected to H1069Q, R778L, and I1102T mutation study. The age range was 5-41 years. Family history was present in 8 patients. The H1069Q, R778L, and I1102T mutations were absent in all the patients and in 16 parents and siblings. Severity of the illness was related to the extent of MRI changes but not with age of onset and hepatic involvement. H1069Q, R778L, and I1102T mutations were absent in our patients, which may be due to genetic and ethnic heterogeneity and further studies are required.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739809     DOI: 10.4103/0028-3886.68678

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  3 in total

Review 1.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

2.  Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.

Authors:  Jayantee Kalita; Vijay Kumar; Abhay Ranjan; Usha K Misra
Journal:  Neuromolecular Med       Date:  2015-07-30       Impact factor: 3.843

Review 3.  Genetics of Wilson's disease: a clinical perspective.

Authors:  S Suresh Kumar; George Kurian; C E Eapen; Eve A Roberts
Journal:  Indian J Gastroenterol       Date:  2012-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.